表紙
市場調査レポート

患者エンゲージメントソリューションの世界市場の予測 〜2020年:コンポーネント・デリバリーモード ・エンドユーザー・用途・治療分野別

Patient Engagement Solutions Market by Component (Hardware, Software & Services), Delivery mode (On-Premise, Web & Cloud), End User (Provider & Payer), Applications (Home Health, Financial Health), Therapeutic Area - Global Forecast to 2020

発行 MarketsandMarkets 商品コード 315355
出版日 ページ情報 英文 232 Pages
即納可能
価格
本日の銀行送金レート: 1USD=106.71円で換算しております。
Back to Top
患者エンゲージメントソリューションの世界市場の予測 〜2020年:コンポーネント・デリバリーモード ・エンドユーザー・用途・治療分野別 Patient Engagement Solutions Market by Component (Hardware, Software & Services), Delivery mode (On-Premise, Web & Cloud), End User (Provider & Payer), Applications (Home Health, Financial Health), Therapeutic Area - Global Forecast to 2020
出版日: 2016年03月16日 ページ情報: 英文 232 Pages
概要

政府による法規制やイニシアチブ、高齢者層における患者管理ソリューションの人気の高まり、ステークホルダーによる大規模な投資、ベンダー・エンドユーザー間の提携の増加などの要因が、患者エンゲージメントソリューションの市場成長に貢献しています。

当レポートは、世界の患者エンゲージメントソリューションの市場を調査し、ソリューションの定義と概要、市場成長への影響因子と市場機会の分析、米国におけるソリューションの導入状況に関する分析、コンポーネント・デリバリーモード・エンドユーザー・用途・疾患区分別の動向と市場規模の推移と予測、競合環境、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 世界の患者エンゲージメントソリューション市場
  • 市場分析:地域・エンドユーザー別
  • 市場の実績・予測:コンポーネント別

第5章 市場概要

  • イントロダクション
  • 市場区分
  • 市場力学
    • 促進因子
    • 阻害因子
    • 機会
    • 課題

第6章 米国の患者エンゲージメントソリューション市場:導入分析

  • イントロダクション
    • 米国:ベンダー別
      • Medical Information Technology, Inc.
      • eClinicalWorks
      • athenahealth, Inc.
      • Allscripts Healthcare Solutions, Inc.
    • 米国:ソリューション別

第7章 市場分析:コンポーネント別

  • イントロダクション
  • ソフトウェア
    • スタンドアロン型
    • 統合型
  • サービス
  • ハードウェア

第8章 市場分析:デリバリーモード別

  • イントロダクション
  • ウェブベース
  • オンプレミス
  • クラウドベース

第9章 市場分析:エンドユーザー別市場

  • イントロダクション
  • 医療提供者
  • 保険者
  • 個人ユーザー
  • その他

第10章 市場分析:用途別

  • イントロダクション
  • 健康管理
  • 社会・行動管理
  • 在宅医療
  • 財政的健全性管理

第11章 市場分析:治療別

  • イントロダクション
  • 慢性疾患
    • 糖尿病
    • 心血管疾患
    • 肥満
    • その他の慢性疾患
  • 婦人科
  • フィットネス
  • その他

第12章 地域分析

  • イントロダクション
  • 北米
  • 欧州
  • アジア
  • その他

第13章 競合環境

  • 概要
  • 競合状況・動向
    • 製品の投入
    • 合意・提携・協力
    • 新製品の投入・製品の強化
    • 拡張
    • 買収
    • その他

第14章 企業プロファイル

  • イントロダクション
  • MCKESSON CORPORATION
  • ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
  • PHYTEL, INC.
  • ATHENAHEALTH, INC.
  • CERNER CORPORATION
  • ORION HEALTH LTD.
  • GETWELLNETWORK, INC.
  • LINCOR SOLUTIONS LTD.
  • YOURCAREUNIVERSE, INC.
  • WELVU, INC.
  • GET REAL HEALTH
  • ONEVIEW HEALTHCARE
  • PATIENTPOINT
  • MEDECISION INC.
  • EMMI SOLUTIONS, LLC
    • 事業概要
    • 製品・サービス
    • 近年の発展動向、など

第15章 付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: HIT 2767

Factors such as government regulations and initiatives, growing popularity of patient engagement solutions among the aging population, significant investments by stakeholders, and rising number of collaborations and partnerships between vendors and end users are some of the factors driving the growth of the patient engagement solutions market. Patient engagement solutions are gaining popularity across the globe; the use of health information technologies and online resources in healthcare boosts care quality by improving care access, efficiency, chronic disease management, and patient & family involvement. Patient engagement solutions offer various features that enhance patient-provider communication and involve patients in their own care. The benefits of patient engagement solutions have fueled their adoption globally. However, reluctance among providers towards the adoption of patient engagement solutions, requirement of infrastructural investments, and lack of interoperability are some of the factors expected to restrain the growth of this market. On the other hand, emerging economies in the Asian region, growing medical tourism, and growing use of cloud-based models offer growth opportunities for players in the market.

The software component segment is estimated to account for the largest share of the global patient engagement solutions market in 2015. Software is a non-tangible component used as an application to run a system or to perform primary tasks, which include maintaining patient records, analyzing databases, and performing administrative tasks in any healthcare organization or hospital.

Geographically, North America is expected to account for the largest share of the global patient engagement solutions market in 2015, followed by Europe, Asia, and the Rest of the World (RoW). The large share of North American is attributed to the federal mandates in the U.S., rising number of ACOs as end users for patient engagement solutions, rising aging population in the U.S, Canada's efforts to enhance healthcare delivery, and digital health measures in Canada.

Major players in the market are focusing on various strategies, such as product deployments; agreements, alliances, collaborations, and partnerships; new product launches (including product enhancements); acquisitions; expansions; and other strategies (divestment, funding, and product integration), to establish a strong foothold in the global patient engagement solutions market.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps the firms to garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the solutions offered by top players in the patient engagement solutions market. The report analyzes the patient engagement solutions market, by component, delivery mode, end user, application, and therapeutic area
  • Product Development/Innovation: Detailed insights on research and development activities and new product launches in the patient engagement solutions market
  • Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the patient engagement solutions market across regions
  • Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the patient engagement solutions market
  • Competitive Assessment: In-depth assessment of strategies, products, and distribution networks of the leading players in the patient engagement solutions market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH METHODOLOGY STEPS
  • 2.2. SECONDARY AND PRIMARY RESEARCH METHODOLOGY
    • 2.2.1. SECONDARY RESEARCH
  • 2.3. KEY DATA FROM SECONDARY SOURCES
    • 2.3.1. PRIMARY RESEARCH
    • 2.3.2. KEY INDUSTRY INSIGHTS
  • 2.4. KEY DATA FROM PRIMARY SOURCES
  • 2.5. KEY INSIGHTS FROM PRIMARY SOURCES
  • 2.6. MARKET SIZE ESTIMATION METHODOLOGY
  • 2.7. MARKET FORECAST METHODOLOGY
  • 2.8. MARKET DATA VALIDATION AND TRIANGULATION
  • 2.9. ASSUMPTIONS

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION
  • 3.2. CURRENT SCENARIO
  • 3.3. FUTURE OUTLOOK
  • 3.4. CONCLUSION

4. PREMIUM INSIGHTS

  • 4.1. GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET
  • 4.2. GEOGRAPHIC ANALYSIS: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER
  • 4.3. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT (2015 VS. 2020)

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET SEGMENTATION
  • 5.3. MARKET DYNAMICS
    • 5.3.1. DRIVERS
      • 5.3.1.1. Government regulations and initiatives
      • 5.3.1.2. Growing popularity of patient engagement solutions among the aging population
      • 5.3.1.3. Significant investments by stakeholders
      • 5.3.1.4. Rising number of collaborations and partnerships between vendors and end users
      • 5.3.1.5. Increasing utilization of mobile health (mhealth)
    • 5.3.2. RESTRAINTS
      • 5.3.2.1. Reluctance among providers towards the adoption of patient engagement solutions
      • 5.3.2.2. Requirement of infrastructural investments
      • 5.3.2.3. Protection of patient information
      • 5.3.2.4. Lack of interoperability
    • 5.3.3. OPPORTUNITIES
      • 5.3.3.1. Emerging economies in the Asian region
      • 5.3.3.2. Growing medical tourism
      • 5.3.3.3. Wearable health technology
      • 5.3.3.4. Cloud-based models
    • 5.3.4. CHALLENGES
      • 5.3.4.1. High cost of deployment
      • 5.3.4.2. Lack of health literacy
      • 5.3.4.3. Dearth of skilled IT professionals in the healthcare industry

6. ADOPTION ASSESSMENT OF PATIENT ENGAGEMENT SOLUTIONS MARKET IN THE U.S.

  • 6.1. INTRODUCTION
    • 6.1.1. U.S.: PATIENT ENGAGEMENT SOLUTIONS ADOPTION ASSESSMENT, BY VENDOR
      • 6.1.1.1. Medical Information Technology, Inc.
      • 6.1.1.2. eClinicalWorks
      • 6.1.1.3. athenahealth, Inc.
      • 6.1.1.4. Allscripts Healthcare Solutions, Inc.
    • 6.1.2. U.S.: PATIENT ENGAGEMENT SOLUTIONS ADOPTION ASSESSMENT, BY SOLUTION

7. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT

  • 7.1. INTRODUCTION
  • 7.2. SOFTWARE
    • 7.2.1. STANDALONE SOFTWARE
    • 7.2.2. INTEGRATED SOFTWARE
  • 7.3. SERVICES
  • 7.4. HARDWARE

8. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE

  • 8.1. INTRODUCTION
  • 8.2. WEB-BASED
  • 8.3. ON-PREMISE
  • 8.4. CLOUD-BASED

9. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER

  • 9.1. INTRODUCTION
  • 9.2. PROVIDERS
  • 9.3. PAYERS
  • 9.4. INDIVIDUAL USERS
  • 9.5. OTHERS

10. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION

  • 10.1. INTRODUCTION
  • 10.2. HEALTH MANAGEMENT
  • 10.3. SOCIAL AND BEHAVIORAL MANAGEMENT
  • 10.4. HOME HEALTH MANAGEMENT
  • 10.5. FINANCIAL HEALTH MANAGEMENT

11. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA

  • 11.1. INTRODUCTION
  • 11.2. CHRONIC DISEASES
    • 11.2.1. DIABETES
    • 11.2.2. CARDIOVASCULAR DISEASE
    • 11.2.3. OBESITY
    • 11.2.4. OTHER CHRONIC DISEASES
  • 11.3. WOMEN'S HEALTH
  • 11.4. FITNESS
  • 11.5. OTHER THERAPEUTIC AREAS

12. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION

  • 12.1. INTRODUCTION
  • 12.2. NORTH AMERICA
    • 12.2.1. U.S.
      • 12.2.1.1. Legislations and initiatives to promote 'patient-centeredness' in healthcare
      • 12.2.1.2. Increasing number of accountable care organizations
      • 12.2.1.3. Need to curb healthcare costs
      • 12.2.1.4. Focus on shared decision-making
      • 12.2.1.5. Hospital Readmissions Reduction Program (HRRP)
      • 12.2.1.6. Pharmaceuticals industry propelling the patient engagement solutions market in U.S.
      • 12.2.1.7. Increase in insurance coverage
      • 12.2.1.8. Increasing investments in patient engagement
      • 12.2.1.9. Impetus on fulfilling the requirements of 'meaningful use' through patient engagement
      • 12.2.1.10. Thrust given to API in stage 3 Meaningful Use Rules
    • 12.2.2. CANADA
      • 12.2.2.1. Digital health measures
      • 12.2.2.2. Prevalence of chronic diseases
      • 12.2.2.3. Patient engagement, a prerequisite for accreditation
  • 12.3. EUROPE
    • 12.3.1. RISING HEALTHCARE COSTS AND AGING POPULATION
    • 12.3.2. GROWTH OF THE HCIT MARKET AND CONSOLIDATION OF HEALTHCARE PROVIDERS IN EUROPE
    • 12.3.3. GROWING FOCUS ON EHEALTH
    • 12.3.4. GERMANY
      • 12.3.4.1. Rising demand for advanced healthcare solutions and efficient healthcare delivery in Germany
    • 12.3.5. U.K.
      • 12.3.5.1. Role of the NHS
    • 12.3.6. FRANCE
      • 12.3.6.1. Implementation of the Dossier Medical Personnel (DMP) in France
    • 12.3.7. REST OF EUROPE (ROE)
  • 12.4. ASIA
    • 12.4.1. GROWTH IN MEDICAL TOURISM
    • 12.4.2. NEED TO CONTROL RISING HEALTHCARE EXPENDITURE IN INDIA
    • 12.4.3. JAPAN'S ICT POLICIES
    • 12.4.4. 'ONE SINGAPOREAN, ONE HEALTH RECORD' PROGRAM
    • 12.4.5. GROWTH OF CHINA'S DIGITAL HEALTHCARE
    • 12.4.6. "DIGITAL INDIA" CAMPAIGN AND DIGITAL HEALTHCARE SCENARIO IN INDIA
  • 12.5. REST OF THE WORLD
    • 12.5.1. PREVALENCE OF CHRONIC DISEASES
    • 12.5.2. INCREASED HEALTHCARE SPENDING IN THE MIDDLE EAST
    • 12.5.3. GROWTH OF THE HCIT MARKET IN LATIN AMERICA
    • 12.5.4. PRODUCT DEPLOYMENTS AND HCIT PROGRAMS IN AUSTRALIA

13. COMPETITIVE LANDSCAPE

  • 13.1. OVERVIEW
  • 13.2. COMPETITIVE SITUATION AND TRENDS
    • 13.2.1. PRODUCT DEPLOYMENTS
    • 13.2.2. AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
    • 13.2.3. NEW PRODUCT LAUNCHES AND PRODUCT ENHANCEMENTS
    • 13.2.4. EXPANSIONS
    • 13.2.5. ACQUISITIONS
    • 13.2.6. OTHER STRATEGIES

14. COMPANY PROFILES

  • 14.1. INTRODUCTION
  • 14.2. MCKESSON CORPORATION
    • 14.2.1. BUSINESS OVERVIEW
    • 14.2.2. PRODUCTS OFFERED
    • 14.2.3. RECENT DEVELOPMENTS
    • 14.2.4. MNM VIEW
  • 14.3. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
    • 14.3.1. BUSINESS OVERVIEW
    • 14.3.2. PRODUCTS & SERVICES OFFERED
    • 14.3.3. RECENT DEVELOPMENTS
    • 14.3.4. MNM VIEW
  • 14.4. PHYTEL, INC. (ACQUIRED BY IBM CORPORATION)
    • 14.4.1. BUSINESS OVERVIEW
    • 14.4.2. PRODUCTS OFFERED
    • 14.4.3. RECENT DEVELOPMENTS
    • 14.4.4. MNM VIEW
  • 14.5. ATHENAHEALTH, INC.
    • 14.5.1. BUSINESS OVERVIEW
    • 14.5.2. PRODUCTS & SERVICES OFFERED
    • 14.5.3. RECENT DEVELOPMENTS
    • 14.5.4. MNM VIEW
  • 14.6. CERNER CORPORATION
    • 14.6.1. BUSINESS OVERVIEW
    • 14.6.2. PRODUCTS OFFERED
    • 14.6.3. RECENT DEVELOPMENTS
    • 14.6.4. MNM VIEW
  • 14.7. ORION HEALTH LTD.
    • 14.7.1. BUSINESS OVERVIEW
    • 14.7.2. PRODUCTS OFFERED
    • 14.7.3. RECENT DEVELOPMENTS
  • 14.8. GETWELLNETWORK, INC.
    • 14.8.1. BUSINESS OVERVIEW
    • 14.8.2. PRODUCTS OFFERED
    • 14.8.3. RECENT DEVELOPMENTS
  • 14.9. LINCOR SOLUTIONS LTD.
    • 14.9.1. BUSINESS OVERVIEW
    • 14.9.2. PRODUCTS OFFERED
    • 14.9.3. RECENT DEVELOPMENTS
  • 14.10. YOURCAREUNIVERSE, INC.
    • 14.10.1. BUSINESS OVERVIEW
    • 14.10.2. PRODUCTS OFFERED
    • 14.10.3. RECENT DEVELOPMENTS
  • 14.11. WELVU, INC.
    • 14.11.1. BUSINESS OVERVIEW
    • 14.11.2. PRODUCTS OFFERED
    • 14.11.3. RECENT DEVELOPMENTS
  • 14.12. GET REAL HEALTH
    • 14.12.1. BUSINESS OVERVIEW
    • 14.12.2. PRODUCTS AND SERVICES OFFERED
    • 14.12.3. RECENT DEVELOPMENTS
  • 14.13. ONEVIEW HEALTHCARE
    • 14.13.1. BUSINESS OVERVIEW
    • 14.13.2. PRODUCTS OFFERED
    • 14.13.3. RECENT DEVELOPMENTS
  • 14.14. PATIENTPOINT
    • 14.14.1. BUSINESS OVERVIEW
    • 14.14.3. RECENT DEVELOPMENTS
  • 14.15. MEDECISION INC.
    • 14.15.1. BUSINESS OVERVIEW
    • 14.15.2. PRODUCTS OFFERED
    • 14.15.3. RECENT DEVELOPMENTS
  • 14.16. EMMI SOLUTIONS, LLC
    • 14.16.1. BUSINESS OVERVIEW
    • 14.16.2. PRODUCTS & SERVICES OFFERED
    • 14.16.3. RECENT DEVELOPMENTS

15. APPENDIX

  • 15.1. DISCUSSION GUIDE
  • 15.2. OTHER DEVELOPMENTS, BY COMPANY (2013-2016)
    • 15.2.1. MCKESSON CORPORATION
    • 15.2.2. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
    • 15.2.3. PHYTEL (ACQUIRED BY IBM)
    • 15.2.4. ATHENAHEALTH, INC.
    • 15.2.5. ORION HEALTH LTD.
    • 15.2.6. CERNER CORPORATION
    • 15.2.7. GETWELLNETWORK, INC.
    • 15.2.8. LINCOR SOLUTIONS LTD.
    • 15.2.9. YOURCAREUNIVERSE, INC.
    • 15.2.10. GET REAL HEALTH
    • 15.2.11. ONEVIEW HEALTHCARE
    • 15.2.12. PATIENTPOINT
    • 15.2.13. MEDECISION INC.
    • 15.2.14. EMMI SOLUTIONS, LLC
  • 15.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 15.4. AVAILABLE CUSTOMIZATIONS
  • 15.5. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: FEDERAL MANDATES ARE PROPELLING THE GROWTH OF GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET
  • TABLE 2: INDICATIVE LIST OF COLLABORATIONS BETWEEN ORGANIZATIONS FROM 2013-2015
  • TABLE 3: RELUCTANCE AMONG PROVIDERS FOR THE ADOPTION OF PATIENT ENGAGEMENT SOLUTIONS ACTS AS A KEY RESTRAINT
  • TABLE 4: CLOUD-BASED PATIENT ENGAGEMENT SOLUTIONS OFFER A HUGE POTENTIAL FOR THE MARKET GROWTH
  • TABLE 5: LACK OF HEALTH LITERACY IS A MAJOR CHALLENGE FOR THE PATIENT ENGAGEMENT SOLUTIONS MARKET
  • TABLE 6: TOP THREE PATIENT ENGAGEMENT SOLUTIONS DEPLOYED (JAN 2013-JAN 2016)
  • TABLE 7: GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY COMPONENT, 2013-2020 (USD MILLION)
  • TABLE 8: PATIENT ENGAGEMENT SOFTWARE MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 9: PATIENT ENGAGEMENT SOFTWARE MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 10: PATIENT ENGAGEMENT STANDALONE SOFTWARE MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 11: PATIENT ENGAGEMENT INTEGRATED SOFTWARE MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 12: PATIENT ENGAGEMENT SERVICES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 13: PATIENT ENGAGEMENT HARDWARE MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 14: GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2013-2020 (USD MILLION)
  • TABLE 15: WEB-BASED PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 16: ON-PREMISE PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 17: CLOUD-BASED PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 18: GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 19: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE FOR HEALTHCARE PROVIDERS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 20: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE FOR HEALTHCARE PAYERS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 21: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE FOR INDIVIDUAL USERS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 22: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE FOR OTHERS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 23: GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 24: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE FOR HEALTH MANAGEMENT, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 25: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE FOR SOCIAL AND BEHAVIORAL MANAGEMENT, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 26: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE FOR HOME HEALTH MANAGEMENT, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 27: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE FOR FINANCIAL HEALTH MANAGEMENT, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 28: GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2013-2020 (USD MILLION)
  • TABLE 29: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE FOR CHRONIC DISEASES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 30: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE FOR CHRONIC DISEASES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 31: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE FOR DIABETES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 32: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE FOR CARDIOVASCULAR DISEASE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 33: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE FOR OBESITY, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 34: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE FOR OTHER CHRONIC DISEASES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 35: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE FOR WOMEN'S HEALTH, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 36: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE FOR FITNESS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 37: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE FOR OTHER THERAPEUTIC AREAS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 38: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 39: NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 40: NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY COMPONENT, 2013-2020 (USD MILLION)
  • TABLE 41: NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2013-2020 (USD MILLION)
  • TABLE 42: NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 43: NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 44: NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2013-2020 (USD MILLION)
  • TABLE 45: U.S.: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY COMPONENT, 2013-2020 (USD MILLION)
  • TABLE 46: U.S.: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2013-2020 (USD MILLION)
  • TABLE 47: U.S.: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 48: U.S.: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 49: U.S.: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2013-2020 (USD MILLION)
  • TABLE 50: CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY COMPONENT, 2013-2020 (USD MILLION)
  • TABLE 51: CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2013-2020 (USD MILLION)
  • TABLE 52: CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 53: CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 54: CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2013-2020 (USD MILLION)
  • TABLE 55: INDICATIVE LIST OF EHEALTH PROJECTS UNDERTAKEN BY THE EUROPEAN UNION
  • TABLE 56: EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 57: EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY COMPONENT, 2013-2020 (USD MILLION)
  • TABLE 58: EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2013-2020 (USD MILLION)
  • TABLE 59: EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 60: EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 61: EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2013-2020 (USD MILLION)
  • TABLE 62: GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY COMPONENT, 2013-2020 (USD MILLION)
  • TABLE 63: GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2013-2020 (USD MILLION)
  • TABLE 64: GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 65: GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 66: GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2013-2020 (USD MILLION)
  • TABLE 67: U.K.: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY COMPONENT, 2013-2020 (USD MILLION)
  • TABLE 68: U.K.: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2013-2020 (USD MILLION)
  • TABLE 69: U.K.: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 70: U.K.: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 71: U.K.: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2013-2020 (USD MILLION)
  • TABLE 72: FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY COMPONENT, 2013-2020 (USD MILLION)
  • TABLE 73: FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2013-2020 (USD MILLION)
  • TABLE 74: FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 75: FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 76: FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2013-2020 (USD MILLION)
  • TABLE 77: ROE: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY COMPONENT, 2013-2020 (USD MILLION)
  • TABLE 78: ROE: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2013-2020 (USD MILLION)
  • TABLE 79: ROE: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 80: ROE: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 81: ROE: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2013-2020 (USD MILLION)
  • TABLE 82: ASIA: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY COMPONENT, 2013-2020 (USD MILLION)
  • TABLE 83: ASIA: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2013-2020 (USD MILLION)
  • TABLE 84: ASIA: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 85: ASIA: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 86: ASIA: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2013-2020 (USD MILLION)
  • TABLE 87: ROW: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY COMPONENT, 2013-2020 (USD MILLION)
  • TABLE 88: ROW: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2013-2020 (USD MILLION)
  • TABLE 89: ROW: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 90: ROW: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY APPLICATION 2013-2020 (USD MILLION)
  • TABLE 91: ROW: PATIENT ENGAGEMENT SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2013-2020 (USD MILLION)
  • TABLE 92: PRODUCT DEPLOYMENTS, 2013-2016
  • TABLE 93: AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 2013-2016
  • TABLE 94: NEW PRODUCT LAUNCHES AND PRODUCT ENHANCEMENTS, 2013-2016
  • TABLE 97: OTHER DEVELOPMENTS, 2013-2016

LIST OF FIGURES

  • FIGURE 1: GLOBAL PATIENT ENGAGEMENT MARKET: RESEARCH METHODOLOGY STEPS
  • FIGURE 2: SAMPLING FRAME: PRIMARY RESEARCH
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 5: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 6: RESEARCH DESIGN
  • FIGURE 7: DATA TRIANGULATION METHODOLOGY
  • FIGURE 8: NORTH AMERICA DOMINATES THE GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET IN 2015
  • FIGURE 9: PROVIDERS SEGMENT TO GROW AT THE HIGHEST CAGR FROM 2015 TO 2020
  • FIGURE 10: EUROPE TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 11: PATIENT ENGAGEMENT SOLUTIONS TO REGISTER DOUBLE DIGIT GROWTH IN THE FORECAST PERIOD
  • FIGURE 12: NORTH AMERICA DOMINATES THE PATIENT ENGAGEMENT SOLUTIONS MARKET IN 2015
  • FIGURE 13: EUROPEAN REGION TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 14: SOFTWARE SEGMENT COMMANDS THE LARGEST SHARE OF THE PATIENT ENGAGEMENT SOLUTIONS MARKET IN 2015
  • FIGURE 15: GLOBAL PATIENT ENGAGEMENT SOLUTIONA MARKET
  • FIGURE 16: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES
  • FIGURE 17: LEADING VENDORS PROVIDING PATIENT ENGAGEMENT SOLUTIONS TO HEALTHCARE PROVIDERS (JAN 2013-JAN 2016)
  • FIGURE 18: PATIENT ENGAGEMENT SOLUTIONS ADOPTED IN U.S. (JAN 2013 TO JAN 2016)
  • FIGURE 20: PATIENT ENGAGEMENT SOFTWARE MARKET, BY TYPE
  • FIGURE 22: HEALTHCARE PROVIDERS TO ACCOUNT FOR THE LARGEST SHARE OF PATIENT ENGAGEMENT SOLUTIONS MARKET IN 2015
  • FIGURE 25: EUROPE TO GROW AT THE HIGHEST CAGR IN THE PATIENT ENGAGEMENT SOLUTIONS MARKET IN 2015
  • FIGURE 26: U.S. COMMANDS THE LARGEST SHARE IN THE PATIENT ENGAGEMENT SOLUTIONS MARKET IN NORTH AMERICA
  • FIGURE 27: GERMANY COMMANDS THE LARGEST SHARE OF THE PATIENT ENGAGEMENT SOLUTIONS MARKET IN EUROPE
  • FIGURE 28: ASIA COMMANDS FOR THE THIRD LARGEST MARKET SHARE OF THE GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET
  • FIGURE 29: PROVIDERS IN END-USERS SEGMENT DOMINATES ROW PATIENT ENGAGEMENT SOLUTIONS MARKET
  • FIGURE 30: TOP 5 STRATEGIES ADOPTED BY PLAYERS DURING 2013-2016
  • FIGURE 31: BATTLE FOR MARKET SHARE: AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS WAS THE KEY STRATEGY ADOPTED BY MARKET PLAYERS (2013-2016)
  • FIGURE 32: GEOGRAPHIC REVENUE MIX OF MARKET PLAYERS
  • FIGURE 33: MCKESSON CORPORATION: COMPANY SNAPSHOT
  • FIGURE 34: ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: COMPANY SNAPSHOT
  • FIGURE 35: IBM CORPORATION: COMPANY SNAPSHOT
  • FIGURE 36: ATHENAHEALTH, INC.: COMPANY SNAPSHOT
  • FIGURE 37: CERNER CORPORATION: COMPANY SNAPSHOT
  • FIGURE 38: ORION HEALTH LTD.: COMPANY SNAPSHOT
Back to Top